Cargando…

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells

Active anti-cancer immune responses depend on efficient presentation of tumor antigens and co-stimulatory signals by antigen-presenting cells (APCs). Therapy with autologous natural APCs is costly and time-consuming and results in variable outcomes in clinical trials. Therefore, development of artif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eggermont, Loek J., Paulis, Leonie E., Tel, Jurjen, Figdor, Carl G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science Publishers 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154451/ https://www.ncbi.nlm.nih.gov/pubmed/24998519 http://dx.doi.org/10.1016/j.tibtech.2014.06.007

Ejemplares similares

Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery
por: Weiden, Jorieke, et al.
Publicado: (2018)

Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation
por: Wauters, Annelies C., et al.
Publicado: (2022)

Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect
por: Hammink, Roel, et al.
Publicado: (2017)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies
por: Neal, Lillian R., et al.
Publicado: (2017)

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses
por: Dölen, Yusuf, et al.
Publicado: (2015)

Harnessing human plasmacytoid dendritic cells as professional APCs
por: Tel, Jurjen, et al.
Publicado: (2012)

Robust Antigen-Specific T Cell Activation within Injectable 3D Synthetic Nanovaccine Depots
por: Weiden, Jorieke, et al.
Publicado: (2021)

Tumoricidal activity of human dendritic cells
por: Tel, Jurjen, et al.
Publicado: (2014)

Enrichment and expansion with nanoscale artificial antigen presenting cells for T cell adoptive immunotherapy
por: Perica, Karlo, et al.
Publicado: (2014)

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues
por: Tel, Jurjen, et al.
Publicado: (2011)

Semiflexible Immunobrushes Induce Enhanced T Cell Activation and Expansion
por: Hammink, Roel, et al.
Publicado: (2021)

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets
por: Sittig, Simone P., et al.
Publicado: (2016)

Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes
por: Ye, Qunrui, et al.
Publicado: (2011)

HLA-Class II Artificial Antigen Presenting Cells in CD4(+) T Cell-Based Immunotherapy
por: Couture, Alexandre, et al.
Publicado: (2019)

Long-lasting multifunctional CD8(+) T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccination
por: Wimmers, Florian, et al.
Publicado: (2015)

Engineering global and local signal generators for probing temporal and spatial cellular signaling dynamics
por: Yang, Haowen, et al.
Publicado: (2023)

Antigen processing and presentation in cancer immunotherapy
por: Lee, Maxwell Y, et al.
Publicado: (2020)

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
por: Schütz, Christian, et al.
Publicado: (2014)

Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
por: Anguille, Sébastien, et al.
Publicado: (2012)

Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases
por: Streeter, Heather B, et al.
Publicado: (2021)

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
por: Le Gall, Camille, et al.
Publicado: (2022)

An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer
por: Wang, Ke-wei, et al.
Publicado: (2022)

Unique pulmonary antigen presentation may call for an alternative approach toward lung cancer immunotherapy
por: Chang, Stephanie, et al.
Publicado: (2013)

Correction: Interleukin-15-Induced CD56(+) Myeloid Dendritic Cells Combine Potent Tumor Antigen Presentation with Direct Tumoricidal Potential
por: Anguille, Sébastien, et al.
Publicado: (2014)

Engineering Metabolism of Chimeric Antigen Receptor (CAR) Cells for Developing Efficient Immunotherapies
por: Mangal, Joslyn L., et al.
Publicado: (2021)

Integrating Immunology and Microfluidics for Single Immune Cell Analysis
por: Sinha, Nidhi, et al.
Publicado: (2018)

Revising immune cell coordination: Origins and importance of single‐cell variation
por: Van Eyndhoven, Laura C., et al.
Publicado: (2022)

Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy
por: Hasan, AN, et al.
Publicado: (2015)

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
por: Chiu, Yen-Ling, et al.
Publicado: (2011)

Advances in artificial intelligence to predict cancer immunotherapy efficacy
por: Xie, Jindong, et al.
Publicado: (2023)

Artificial Intelligence in Digital Pathology to Advance Cancer Immunotherapy
por: Chen, Pingjun, et al.
Publicado: (2022)

New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
por: Biagi, Ettore, et al.
Publicado: (2011)

Antigen Targets for the Development of Immunotherapies in Leukemia
por: Bauer, Jens, et al.
Publicado: (2019)

Lipid peroxidation causes endosomal antigen release for cross-presentation
por: Dingjan, Ilse, et al.
Publicado: (2016)

Bioengineering of Artificial Antigen Presenting Cells and Lymphoid Organs
por: Wang, Chao, et al.
Publicado: (2017)

Magnetically induced enzymatic cascades – advancing towards multi-fuel direct/mediated bioelectrocatalysis
por: Herkendell, Katharina, et al.
Publicado: (2019)

Immune infiltrates impact on the prediction of prognosis and response to immunotherapy of melanoma patients
por: Vasaturo, Angela, et al.
Publicado: (2015)

Single-step nanoparticle antigen presentation system for tumor immunotherapy
por: Kohlhapp, Frederick, et al.
Publicado: (2015)

Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
por: Wang, Shixiang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4l8pgd4fhmnatvh01im5aoa76l